A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer
NCT07591090
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Breast Cancer
Interventions
DRUG:
AK146D1 for injection
DRUG:
AK112 Injection
Sponsor
Akeso